Delivery Order FA486121D0004-FA486124F0079
Award Date 3/16/24
Potential Completion Date 3/15/25
Potential Value $125K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Nellis AFB, NV, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of the Air Force Air Combat Command awarded a $124,588.79 firm fixed price delivery order to Genomic Health, Inc. for Oncotype DX cancer testing services during the ordering period from March 2023 through March 2024. Genomic Health is a subsidiary of Exact Sciences Corporation which will perform the testing through its laboratory services division Exact Sciences Laboratories. The delivery order was awarded without a set-aside designation to support the Air Force's cancer screening...
- Genomic Health, Inc., a subsidiary of Exact Sciences Corp, has been awarded a $62,259.50 firm fixed price delivery order against an unspecified contract vehicle to provide oncotype dx cancer testing services for the United States Air Force Air Combat Command located at Nellis Air Force Base in Nevada. Oncotype dx cancer testing analyzes gene expression in breast and prostate cancers to determine a recurrence score that predicts the likelihood of cancer returning after initial treatment. The...
- This is a Definitive Contract awarded by the Defense Health Agency to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for Oncotype DX cancer testing services. The $642,816.16 firm fixed-price contract covers the provision of these specialized genomic diagnostic services to various military and veterans' healthcare facilities, including Travis Air Force Base, from January 1, 2020 to March 31, 2025. Genomic Health, Inc. has significant federal Indefinite Delivery Vehicle (IDV)...
- Genomic Health, Inc., a subsidiary of Exact Sciences Corp, has been awarded a $141,858.59 firm fixed price delivery order contract by the Department of the Air Force Air Combat Command. The contract calls for Genomic Health to provide Oncotype DX cancer testing services to support the agency's medical programs. Performance will take place in Las Vegas, Nevada. No set-aside provisions were applied to this award. Genomic Health will leverage its subsidiary Exact Sciences Laboratories to fulfill...
- This federal contract award is for the Oncotype DX laboratory test, which was awarded to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract, awarded by the Department of the Army Medical Command, has a potential value of $250,000.00 and is a firm fixed price purchase order with no set-aside designation. Genomic Health has a history of federal contracts to provide cancer testing services, including its Oncotype DX portfolio, to the Defense Health Agency, Department...
- This is a firm fixed-price delivery order awarded by the Air Education and Training Command, a defense agency, to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract, valued at $3,453.96, is for the provision of Oncotype DX Pathology Tests, which are advanced genomic cancer diagnostic services. This order is placed under the Medical Laboratory Testing and Analysis Services contract vehicle, a General Services Administration (GSA) schedule. Genomic Health provides these...
- This federal contract award is for the provision of 2 Oncotype DX Pathology Tests by Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract was awarded by the Air Education and Training Command, a defense agency, and has a ceiling value of $6,907.92. It is a firm fixed-price delivery order contract under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract does not have a set-aside designation. Genomic Health, Inc. is the...
- The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for cancer testing services. The potential value of the contract is $124,081.53, with a completion date of September 30, 2019. Genomic Health has provided cancer testing services, including its Oncotype DX portfolio of assays, to the Department of Defense and Department of Veterans Affairs under past federal contracts. This award is...
- This federal contract award to Genomic Health, Inc. is for the provision of breast cancer testing services to the Defense Health Agency (DHA), a defense agency within the U.S. Department of Defense. The $125,000.00 Firm Fixed Price Blanket Purchase Agreement (BPA) contract does not utilize any set-aside designations and was awarded on September 21, 2016, with a completion date of September 20, 2017. Genomic Health, a subsidiary of Exact Sciences Corporation, specializes in genomic-based cancer...
- This federal contract award is for Oncotype DX breast cancer testing services provided by Genomic Health, Inc. to the Defense Health Agency. The $13,815.84 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call, with a performance period ending on May 31, 2018. Genomic Health, a subsidiary of Exact Sciences Corporation, is a for-profit organization that specializes in providing advanced genetic testing services to federal healthcare systems. The company has several large Indefinite...